Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Blankenstein

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1997
Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentationS Cayeux, G Richter, G Noffz, et al.
Molecular Immunology|March 1, 1989
Recombination between VH pseudogenesT Blankenstein, G A Rathbun, P W Tucker, et al.
The Journal of Experimental Medicine|December 6, 2001
Tumor rejection by disturbing tumor stroma cell interactionsS Ibe, Z Qin, T Schüler, et al.
The Journal of Experimental Medicine|March 2, 1999
T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient miceT Schüler, Z Qin, S Ibe, et al.
European Journal of Immunology|April 1, 1993
Eosinophils infiltrating interleukin-5 gene-transfected tumors do not suppress tumor growthS Krüger-Krasagakes, W Li, G Richter, et al.
Immunogenetics|January 1, 1991
The interleukin-6 gene locus seems to be a preferred target site for retrotransposon integrationZ H Qin, I Schuller, G Richter, et al.
Immunology Today|December 1, 1990
Tumor cell targeted cytokine (TNF-alpha) gene therapy for cancerT Blankenstein, Z Qin, K Uberla, et al.
Blood|May 15, 1995
Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in miceZ Qin, L J van Tits, W A Buurman, et al.
Human Gene Therapy|December 16, 1998
RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypesW Uckert, G Willimsky, F S Pedersen, et al.
Human Gene Therapy|December 1, 1995
The thymidine kinase/ganciclovir-mediated "suicide" effect is variable in different tumor cellsC Beck, S Cayeux, S D Lupton, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1997
Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentationS Cayeux, G Richter, G Noffz, et al.
Molecular Immunology|March 1, 1989
Recombination between VH pseudogenesT Blankenstein, G A Rathbun, P W Tucker, et al.
The Journal of Experimental Medicine|December 6, 2001
Tumor rejection by disturbing tumor stroma cell interactionsS Ibe, Z Qin, T Schüler, et al.
The Journal of Experimental Medicine|March 2, 1999
T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient miceT Schüler, Z Qin, S Ibe, et al.
European Journal of Immunology|April 1, 1993
Eosinophils infiltrating interleukin-5 gene-transfected tumors do not suppress tumor growthS Krüger-Krasagakes, W Li, G Richter, et al.
Immunogenetics|January 1, 1991
The interleukin-6 gene locus seems to be a preferred target site for retrotransposon integrationZ H Qin, I Schuller, G Richter, et al.
Immunology Today|December 1, 1990
Tumor cell targeted cytokine (TNF-alpha) gene therapy for cancerT Blankenstein, Z Qin, K Uberla, et al.
Blood|May 15, 1995
Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in miceZ Qin, L J van Tits, W A Buurman, et al.
Human Gene Therapy|December 16, 1998
RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypesW Uckert, G Willimsky, F S Pedersen, et al.
Human Gene Therapy|December 1, 1995
The thymidine kinase/ganciclovir-mediated "suicide" effect is variable in different tumor cellsC Beck, S Cayeux, S D Lupton, et al.
Pageof 10